[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Drbagholders Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1351507242206580736.png) @Drbagholders DrBagholder

DrBagholder posts on X about $sgmo, $novo, novo, $embrac the most. They currently have XXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::1351507242206580736/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:interactions.svg)

- X Week XXXXX -XX%
- X Month XXXXX +1,973%
- X Months XXXXXX +22%
- X Year XXXXXX +1,869%

### Mentions: X [#](/creator/twitter::1351507242206580736/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:posts_active.svg)

- X Week X +13%
- X Month XX +180%
- X Months XX +71%
- X Year XX +529%

### Followers: XXX [#](/creator/twitter::1351507242206580736/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:followers.svg)

- X Week XXX +5.10%
- X Month XXX +11%
- X Months XXX +111%
- X Year XXX +85%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::1351507242206580736/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1351507242206580736/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::1351507242206580736/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX% [technology brands](/list/technology-brands)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$sgmo](/topic/$sgmo) #15, [$novo](/topic/$novo) #2, [novo](/topic/novo) 10.53%, [$embrac](/topic/$embrac) 5.26%, [$asmodee](/topic/$asmodee) 5.26%, [$acast](/topic/$acast) 5.26%, [$hnsa](/topic/$hnsa) 5.26%, [$googl](/topic/$googl) 5.26%, [$ampx](/topic/$ampx) 5.26%, [$ntla](/topic/$ntla) XXXX%

**Top accounts mentioned or mentioned by**
[@jrunestam](/creator/undefined) [@seharvest](/creator/undefined) [@alc2022](/creator/undefined) [@engbl0m](/creator/undefined)

**Top assets mentioned**
[Alphabet Inc Class A (GOOGL)](/topic/$googl) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [uniQure N.V. (QURE)](/topic/$qure)
### Top Social Posts [#](/creator/twitter::1351507242206580736/posts)
---
Top posts by engagements in the last XX hours

"$EMBRAC Embracer Group $ASMODEE Asmodee $ACAST - Acast $HNSA - Hansa Biopharma"  
[X Link](https://x.com/Drbagholders/status/1975614548364406965) [@Drbagholders](/creator/x/Drbagholders) 2025-10-07T17:29Z XXX followers, 1154 engagements


"💼 $GOOGL Google $AMPX Amprius Technologies $NTLA Intellia Therapeutics $MDXH MDxHealth $AIRO Airo Group $OSSD OssDsign $SGMO Sangamo Therapeutics $SRPT Sarepta Therapeutics $NKTR Nektar Therapeutics $MCLAIR Medclair $NOVO Novo Nordisk $BIOA BioArctic"  
[X Link](https://x.com/Drbagholders/status/1975612700110794883) [@Drbagholders](/creator/x/Drbagholders) 2025-10-07T17:22Z XXX followers, 1296 engagements


"This years Nobel price in Physics goes to Sangamos management for bending the laws of market gravity by keeping the stock under $X despite stellar Fabry data in a raging bull market. Truly groundbreaking $SGMO"  
[X Link](https://x.com/Drbagholders/status/1975498883175489699) [@Drbagholders](/creator/x/Drbagholders) 2025-10-07T09:50Z XXX followers, 4468 engagements


"$S sentinelone breakout"  
[X Link](https://x.com/Drbagholders/status/1968679822923534758) [@Drbagholders](/creator/x/Drbagholders) 2025-09-18T14:13Z XXX followers, XXX engagements


"Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 2025 World Muscle Society Congress"  
[X Link](https://x.com/Drbagholders/status/1974433910617452873) [@Drbagholders](/creator/x/Drbagholders) 2025-10-04T11:18Z XXX followers, XXX engagements


"$QURE (the bull thesis)"  
[X Link](https://x.com/Drbagholders/status/1976951172486644220) [@Drbagholders](/creator/x/Drbagholders) 2025-10-11T10:01Z XXX followers, 1315 engagements


"Omeros Corporation - Novo Nordisk and Omeros announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart (OMS906) $NOVO $OMER"  
[X Link](https://x.com/Drbagholders/status/1978535133922652179) [@Drbagholders](/creator/x/Drbagholders) 2025-10-15T18:55Z XXX followers, XXX engagements